文献速递疼痛医学神经外科与老年麻醉

原发性三叉神经痛急性发作的补救镇痛策略系统综述

A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia.
PubMed 文献 · Br J Anaesth · 2019-06-15

该系统综述检索Medline和Cochrane CENTRAL,纳入17项报告三叉神经痛急性治疗即刻结果的研究,旨在识别24小时内有效缓解原发性三叉神经痛急性发作的治疗。证据提示局麻药(主要为利多卡因)、抗惊厥药(苯妥英或磷苯妥英静脉输注)及5-HT激动剂舒马曲普坦可能有益,其他干预证据非常有限。

要点

  • 利多卡因多种途径(眼、鼻、口腔黏膜、触发点注射、静脉输注、神经阻滞)可能急性缓解三叉神经痛。
  • 苯妥英或磷苯妥英静脉输注、舒马曲普坦皮下或鼻内给药可能有益。
  • 硫酸镁输注和肉毒毒素触发点注射证据非常有限。

核心结论

  • 多种治疗选择可能快速、安全地缓解三叉神经痛急性发作。
  • 未来研究应在24小时内报告结局以增进对急性镇痛治疗的了解。

研究设计与样本

  • 系统综述,检索Medline和Cochrane CENTRAL英文文献并追溯参考文献。
  • 从431项研究中纳入17项报告三叉神经痛急性治疗即刻结果的研究。
  • 纳入标准:成人原发性三叉神经痛急性发作,任何以24小时内镇痛为主要目标的干预,对照为常规医疗、安慰剂、假干预或活性治疗,结局为给药24小时内疼痛强度降低超过50%。

主要发现

  • 证据提示局麻药(主要为利多卡因,眼、鼻或口腔黏膜、触发点注射、静脉输注、神经阻滞)可能有益。
  • 证据提示抗惊厥药苯妥英或磷苯妥英静脉输注可能有益。
  • 证据提示5-HT激动剂舒马曲普坦皮下注射或鼻内给药可能有益。
  • 其他提及的干预包括N-甲基-D-天冬氨酸受体拮抗剂(硫酸镁输注)和肉毒毒素(触发点注射),但证据非常有限。

临床怎么用

  • 对原发性三叉神经痛急性发作,可考虑利多卡因(多种途径)、苯妥英或磷苯妥英静脉输注、舒马曲普坦皮下或鼻内给药以快速镇痛。
  • 硫酸镁输注和肉毒毒素触发点注射因证据非常有限,使用需谨慎。

局限性

  • 符合纳入标准的研究仅17项,急性治疗数据有限。
  • 部分干预(硫酸镁、肉毒毒素)证据非常有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trigeminal neuralgia (TN) can have a significant impact on wellbeing and quality of life. Limited data exist for treatments that improve TN pain acutely, within 24 h of administration. This systematic review aims to identify effective treatments that acutely relieve TN exacerbations. METHODS: We searched Medline and Cochrane Central Register of Controlled Trials (CENTRAL) for relevant English language publications. The reference list for all articles was searched for other relevant publications. All studies that satisfied the following PICO criteria were included: (i) Population-adults with acute exacerbation of primary TN symptoms; (ii) Intervention-any medication or intervention with the primary goal of pain relief within 24 h; (iii) Comparator-usual medical care, placebo, sham or active treatment; (iv) Outcome-more than 50% reduction in pain intensity within 24 h of administration. RESULTS: Of 431 studies, 17 studies were identified that reported immediate results of acute treatment in TN. The evidence suggests that the following interventions may be beneficial: local anaesthetic, mainly lidocaine (ophthalmic, nasal or oral mucosa, trigger point injection, i.v. infusion, nerve block); anticonvulsant, phenytoin or fosphenytoin (i.v. infusion); serotonin agonist, sumatriptan (s.c. injection, nasal). Other referenced interventions with very limited evidence include N-methyl-d-aspartate receptor antagonist (magnesium sulphate infusion) and botulinum toxin (trigger point injection). CONCLUSIONS: Several treatment options exist that may provide fast and safe relief of TN. Future studies should report on outcomes within 24 h to improve knowledge of the acute analgesic TN treatments.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Moore D, Chong MS, Shetty A, et al. A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia. Br J Anaesth. 2019. PMID: 31208761. doi:10.1016/j.bja.2019.05.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。